BCYC
Price
$8.66
Change
-$0.07 (-0.80%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
519.71M
8 days until earnings call
RLAY
Price
$3.11
Change
+$0.18 (+6.14%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
496.7M
8 days until earnings call
Ad is loading...

BCYC vs RLAY

Header iconBCYC vs RLAY Comparison
Open Charts BCYC vs RLAYBanner chart's image
Bicycle Therapeutics
Price$8.66
Change-$0.07 (-0.80%)
Volume$6.75K
Capitalization519.71M
Relay Therapeutics
Price$3.11
Change+$0.18 (+6.14%)
Volume$42.1K
Capitalization496.7M
BCYC vs RLAY Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. RLAY commentary
Apr 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and RLAY is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 23, 2025
Stock price -- (BCYC: $8.73 vs. RLAY: $2.93)
Brand notoriety: BCYC and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 223% vs. RLAY: 75%
Market capitalization -- BCYC: $519.71M vs. RLAY: $496.7M
BCYC [@Biotechnology] is valued at $519.71M. RLAY’s [@Biotechnology] market capitalization is $496.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $285.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 4 bearish.
  • RLAY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а +12.07% price change this week, while RLAY (@Biotechnology) price change was +6.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.67%. For the same industry, the average monthly price growth was -9.26%, and the average quarterly price growth was -12.98%.

Reported Earning Dates

BCYC is expected to report earnings on Jul 31, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($520M) and RLAY($497M) have the same market capitalization . RLAY YTD gains are higher at: -28.883 vs. BCYC (-37.643). BCYC has higher annual earnings (EBITDA): -164.89M vs. RLAY (-380.21M). BCYC has more cash in the bank: 880M vs. RLAY (781M). BCYC has less debt than RLAY: BCYC (9.49M) vs RLAY (48.5M). BCYC has higher revenues than RLAY: BCYC (35.3M) vs RLAY (10M).
BCYCRLAYBCYC / RLAY
Capitalization520M497M105%
EBITDA-164.89M-380.21M43%
Gain YTD-37.643-28.883130%
P/E RatioN/AN/A-
Revenue35.3M10M353%
Total Cash880M781M113%
Total Debt9.49M48.5M20%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCRLAY
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSCYX8.48N/A
N/A
Victory RS Small Cap Equity Y
HOOCX23.84N/A
N/A
Hartford Schroders US Small Cap Opps C
CMIUX13.84N/A
N/A
Six Circles Mgd Eq Port Intl Uncons
TGCNX19.51N/A
N/A
TCW Concentrated Large Cap Growth N Cl
IASRX20.22N/A
N/A
Macquarie Asset Strategy Fund Cl R

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+16.24%
INO - BCYC
51%
Loosely correlated
+3.93%
RPTX - BCYC
49%
Loosely correlated
+14.17%
XNCR - BCYC
48%
Loosely correlated
+0.47%
RLAY - BCYC
48%
Loosely correlated
+6.55%
FHTX - BCYC
41%
Loosely correlated
+8.72%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+6.55%
XNCR - RLAY
50%
Loosely correlated
+0.47%
BCYC - RLAY
48%
Loosely correlated
+16.24%
RXRX - RLAY
47%
Loosely correlated
+4.07%
FHTX - RLAY
45%
Loosely correlated
+8.72%
RVMD - RLAY
44%
Loosely correlated
+0.82%
More